Ingela Marianne Svan

Title: Ingela Marianne Svan: Innovator in Dopamine Modulation

Introduction

Ingela Marianne Svan is a prominent inventor based in Göteborg, Sweden. She has made significant contributions to the field of neuroscience through her innovative work on dopamine neurotransmission. With a total of 3 patents, her research focuses on developing compounds that can potentially treat disorders in the central nervous system.

Latest Patents

Ingela's latest patents include novel 3-substituted 4-(phenyl-N-alkyl)-piperazine and 4-(phenyl-N-alkyl)-piperidine compounds. These compounds are characterized by specific chemical formulas that allow for modulation of dopamine neurotransmission. The patents disclose various pharmaceutical compositions and methods for using these compounds in treating central nervous system disorders.

Career Highlights

Throughout her career, Ingela has worked with notable companies such as A. Carlsson Research AB and Neurosearch Sweden AB. Her work has been instrumental in advancing the understanding of dopamine-related treatments. Ingela's innovative approach has positioned her as a key figure in her field.

Collaborations

Ingela has collaborated with esteemed colleagues, including Clas Sonesson and Joakim Tedroff. These partnerships have further enriched her research and contributed to her success in the industry.

Conclusion

Ingela Marianne Svan's contributions to the field of neuroscience through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in the treatment of central nervous system disorders.